• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药用植物、植物化学物质和草药对抗包括 SARS-CoV-2 在内的病毒病原体。

Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2.

机构信息

Medical Genetics and Epigenetics Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore 641046, India.

Department of Food Science and Biotechnology, College of Life Science, Sejong University, Seoul 05006, Korea.

出版信息

Molecules. 2021 Mar 22;26(6):1775. doi: 10.3390/molecules26061775.

DOI:10.3390/molecules26061775
PMID:33809963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8004635/
Abstract

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome corona virus-2 (SARS-CoV-2), is the most important health issue, internationally. With no specific and effective antiviral therapy for COVID-19, new or repurposed antiviral are urgently needed. Phytochemicals pose a ray of hope for human health during this pandemic, and a great deal of research is concentrated on it. Phytochemicals have been used as antiviral agents against several viruses since they could inhibit several viruses via different mechanisms of direct inhibition either at the viral entry point or the replication stages and via immunomodulation potentials. Recent evidence also suggests that some plants and its components have shown promising antiviral properties against SARS-CoV-2. This review summarizes certain phytochemical agents along with their mode of actions and potential antiviral activities against important viral pathogens. A special focus has been given on medicinal plants and their extracts as well as herbs which have shown promising results to combat SARS-CoV-2 infection and can be useful in treating patients with COVID-19 as alternatives for treatment under phytotherapy approaches during this devastating pandemic situation.

摘要

新型冠状病毒病(COVID-19)大流行是由严重急性呼吸系统综合征冠状病毒 2 型(SARS-CoV-2)引起的,这是国际上最重要的健康问题。由于目前尚无针对 COVID-19 的特效抗病毒疗法,因此急需新型或重新定位的抗病毒药物。在这场大流行期间,植物化学物质为人类健康带来了一线希望,大量研究都集中在这方面。植物化学物质已被用作针对多种病毒的抗病毒药物,因为它们可以通过不同的机制直接抑制病毒,要么在病毒进入点,要么在复制阶段,并通过免疫调节潜力。最近的证据还表明,一些植物及其成分对 SARS-CoV-2 表现出有希望的抗病毒特性。本文综述了某些植物化学物质及其作用方式,以及它们针对重要病毒病原体的潜在抗病毒活性。特别关注了药用植物及其提取物以及草药,它们在对抗 SARS-CoV-2 感染方面显示出有希望的结果,并可作为 COVID-19 患者治疗的替代方法,在这种破坏性大流行情况下,作为植物疗法方法的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cae4/8004635/8a872bf0e664/molecules-26-01775-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cae4/8004635/b488ce7a1bcb/molecules-26-01775-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cae4/8004635/4ec68dc25736/molecules-26-01775-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cae4/8004635/89f0eca5daeb/molecules-26-01775-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cae4/8004635/8a872bf0e664/molecules-26-01775-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cae4/8004635/b488ce7a1bcb/molecules-26-01775-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cae4/8004635/4ec68dc25736/molecules-26-01775-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cae4/8004635/89f0eca5daeb/molecules-26-01775-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cae4/8004635/8a872bf0e664/molecules-26-01775-g004.jpg

相似文献

1
Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2.药用植物、植物化学物质和草药对抗包括 SARS-CoV-2 在内的病毒病原体。
Molecules. 2021 Mar 22;26(6):1775. doi: 10.3390/molecules26061775.
2
Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.植物化学制剂对 SARS-CoV 的作用及其在 COVID-19 中应用的选择:一个小型综述。
Curr Pharm Biotechnol. 2021;22(4):444-450. doi: 10.2174/1389201021666200703201458.
3
Systematic Review on Major Antiviral Phytocompounds from Common Medicinal Plants against SARS-CoV-2.常见药用植物中抗SARS-CoV-2主要抗病毒植物化合物的系统评价
Med Chem. 2024;20(6):613-629. doi: 10.2174/0115734064262843231120051452.
4
The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection.天然草药和蘑菇的抗病毒、抗炎作用与 SARS-CoV-2 感染。
Nutrients. 2020 Aug 25;12(9):2573. doi: 10.3390/nu12092573.
5
Exploring the therapeutic potential of Thai medicinal plants: in vitro screening and in silico docking of phytoconstituents for novel anti-SARS-CoV-2 agents.探索泰国药用植物的治疗潜力:用于新型抗 SARS-CoV-2 药物的植物成分的体外筛选和计算机对接。
BMC Complement Med Ther. 2024 Jul 19;24(1):274. doi: 10.1186/s12906-024-04586-z.
6
Traditional herbs against COVID-19: back to old weapons to combat the new pandemic.传统草药防治 COVID-19:用老武器对抗新疫情。
Eur J Med Res. 2022 Sep 26;27(1):186. doi: 10.1186/s40001-022-00818-5.
7
Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).药用植物和次生代谢物抗严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)的作用机制。
Curr Pharm Des. 2021;27(38):3996-4007. doi: 10.2174/1381612827666210705160130.
8
Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: A review.药用植物在治疗病毒病中的潜在作用,重点关注 COVID-19:综述。
Phytother Res. 2021 Mar;35(3):1298-1312. doi: 10.1002/ptr.6893. Epub 2020 Oct 9.
9
In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection.计算机筛选鉴定抗 SARS-CoV-2 感染人类蛋白酶的潜在天然产物抑制剂。
Molecules. 2020 Aug 22;25(17):3822. doi: 10.3390/molecules25173822.
10
An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery.贝塔冠状病毒病毒进入抑制剂的最新综述:从过去的发现中吸取教训,推进 COVID-19 药物发现。
Curr Top Med Chem. 2021;21(7):571-596. doi: 10.2174/1568026621666210119111409.

引用本文的文献

1
Exploring the Multifaceted Potential of L.: A Comprehensive Review of Its Nutritional, Pharmacological, and Environmental Significance.探索L.的多方面潜力:对其营养、药理和环境意义的全面综述。
Food Sci Nutr. 2025 Jul 4;13(7):e70486. doi: 10.1002/fsn3.70486. eCollection 2025 Jul.
2
Plant-Based Diet and Sports Performance.以植物为基础的饮食与运动表现
ACS Omega. 2024 Nov 7;9(49):47939-47950. doi: 10.1021/acsomega.4c07560. eCollection 2024 Dec 10.
3
The Role of Epigallocatechin Gallate (EGCG) in Treatment and Management of Sexually Transmitted Viral Infections.

本文引用的文献

1
Molecular docking reveals the potential of flavonoids to inhibit COVID-19 virus main protease.分子对接揭示了黄酮类化合物抑制新冠病毒主要蛋白酶的潜力。
RSC Adv. 2020 May 21;10(33):19570-19575. doi: 10.1039/d0ra03582c. eCollection 2020 May 20.
2
screening and covalent binding of phytochemicals of against SARS-CoV-2 (COVID 19) main protease.针对严重急性呼吸综合征冠状病毒2(新冠病毒19)主要蛋白酶的植物化学物质的筛选与共价结合
J Biomol Struct Dyn. 2023 Feb;41(2):435-444. doi: 10.1080/07391102.2021.2007170. Epub 2021 Nov 25.
3
Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis.
表没食子儿茶素没食子酸酯(EGCG)在性传播病毒感染治疗与管理中的作用
Infect Disord Drug Targets. 2025;25(4):e18715265319110. doi: 10.2174/0118715265319110240916061200.
4
A critical review on phytochemicals as antiviral medications for SARS-CoV-2 virus infection.关于植物化学物质作为抗SARS-CoV-2病毒感染抗病毒药物的批判性综述。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2053-2069. doi: 10.1007/s00210-024-03467-z. Epub 2024 Oct 1.
5
Quest for Anti-SARS-CoV-2 antiviral therapeutics: in-silico and in-vitro analysis of edible mushroom- Cordyceps militaris.抗新型冠状病毒2型抗病毒疗法的探索:蛹虫草的计算机模拟和体外分析
J Ayurveda Integr Med. 2024 May-Jun;15(3):100979. doi: 10.1016/j.jaim.2024.100979. Epub 2024 Jun 12.
6
Phytoconstituents of Artemisia Annua as potential inhibitors of SARS CoV2 main protease: an in silico study.黄花蒿植物成分作为 SARS-CoV-2 主蛋白酶潜在抑制剂的研究:一项计算机模拟研究。
BMC Infect Dis. 2024 May 15;24(1):495. doi: 10.1186/s12879-024-09387-w.
7
Kaempferol: A Review of Current Evidence of Its Antiviral Potential.山奈酚:其抗病毒潜力的当前证据综述。
Int J Mol Sci. 2023 Nov 14;24(22):16299. doi: 10.3390/ijms242216299.
8
Possible high risk of transmission of the Nipah virus in South and South East Asia: a review.南亚和东南亚地区尼帕病毒传播的潜在高风险:综述
Trop Med Health. 2023 Aug 10;51(1):44. doi: 10.1186/s41182-023-00535-7.
9
COVID-19 associated thyroid dysfunction and other comorbidities and its management using phytochemical-based therapeutics: a natural way.COVID-19 相关甲状腺功能障碍及其他合并症及其基于植物化学物质的治疗管理:一种自然途径。
Biosci Rep. 2023 Jul 26;43(7). doi: 10.1042/BSR20230293.
10
Medicinal Plants for Viral Respiratory Diseases: A Systematic Review on Persian Medicine.用于病毒性呼吸道疾病的药用植物:波斯医学的系统评价
Evid Based Complement Alternat Med. 2023 Feb 10;2023:1928310. doi: 10.1155/2023/1928310. eCollection 2023.
通过分子对接和药理学分析评估黄酮类化合物作为2019新型冠状病毒细胞进入抑制剂的作用
Heliyon. 2021 Mar;7(3):e06515. doi: 10.1016/j.heliyon.2021.e06515. Epub 2021 Mar 14.
4
Roles of flavonoids against coronavirus infection.黄酮类化合物对抗冠状病毒感染的作用。
Chem Biol Interact. 2020 Sep 1;328:109211. doi: 10.1016/j.cbi.2020.109211. Epub 2020 Jul 28.
5
COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines.新型冠状病毒肺炎(COVID-19)——新型疫苗候选物的最新研究进展和即将面世的 SARS-CoV-2 疫苗的现状。
Hum Vaccin Immunother. 2020 Dec 1;16(12):2891-2904. doi: 10.1080/21645515.2020.1788310. Epub 2020 Jul 23.
6
Withaferin A: a potential therapeutic agent against COVID-19 infection.醉茄素 A:一种对抗 COVID-19 感染的潜在治疗药物。
J Ovarian Res. 2020 Jul 19;13(1):79. doi: 10.1186/s13048-020-00684-x.
7
Identification of bioactive molecule from (Ashwagandha) as SARS-CoV-2 main protease inhibitor.从 (印度人参)中鉴定出生物活性分子作为 SARS-CoV-2 主蛋白酶抑制剂。
J Biomol Struct Dyn. 2021 Sep;39(15):5668-5681. doi: 10.1080/07391102.2020.1790425. Epub 2020 Jul 8.
8
Curcumin: a Wonder Drug as a Preventive Measure for COVID19 Management.姜黄素:一种作为新冠病毒管理预防措施的神奇药物。
Indian J Clin Biochem. 2020 Jul;35(3):373-375. doi: 10.1007/s12291-020-00902-9. Epub 2020 Jun 17.
9
Is hydroxychloroquine beneficial for COVID-19 patients?羟氯喹对 COVID-19 患者有益吗?
Cell Death Dis. 2020 Jul 8;11(7):512. doi: 10.1038/s41419-020-2721-8.
10
Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19).槲皮素和维生素 C:预防和治疗 SARS-CoV-2 相关疾病(COVID-19)的实验性协同治疗方法。
Front Immunol. 2020 Jun 19;11:1451. doi: 10.3389/fimmu.2020.01451. eCollection 2020.